Efgartigimod

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

A Study of Efgartigimod in Patients With IgG4-Related Disease

A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)

Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS

Efgartigimod for Stiff Person Syndrome (ESPS)

Efgartigimod for the Treatment of Guillain-Barré Syndrome

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Seronegative Myasthenia Gravis - Efgartigimod IV

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)